Translational Investigation Group of Critical Patient. Mechanism of cell injury
Celular injury in critical patient
Université Libre de Bruxelles
Bruselas, BélgicaPublications in collaboration with researchers from Université Libre de Bruxelles (2)
2021
-
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety
Expert Review of Cardiovascular Therapy, Vol. 19, Núm. 4, pp. 325-335
2020
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22